Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Movement Disorders Clinical Practice|October 27, 2018
The Clinical Spectrum of Ataxia with Oculomotor Apraxia Type 2Florian Brugger, Michael Schüpbach, Michel Koenig, et al.
The International Journal of Neuroscience|November 27, 2013
Antimyelin antibodies as predictors of disability after clinically isolated syndromeOliver Findling, Isabelle Durot, Anja Weck, et al.
Frontiers in Neurology|October 27, 2018
Role of Family Planning in Women With Multiple Sclerosis in Switzerland: Results of the Women With Multiple Sclerosis Patient SurveyChristian P Kamm, Sarah Muehl, Dennis Mircsof, et al.
Disability and Rehabilitation. Assistive Technology|October 29, 2022
Tablet app-based dexterity training in multiple sclerosis (TAD-MS): a randomized controlled trialJudith J W van Beek, Dirk Lehnick, Manuela Pastore-Wapp, et al.
Plastic and Reconstructive Surgery|May 13, 2025
Lower extremity nerve decompression for superimposed peripheral neuropathy in diabetes: awareness among medical professionalsNadine Boers, Isabelle M L P Kamm, Manuel Castro Cabezas, et al.
Multiple Sclerosis and Related Disorders|December 10, 2022
Factors associated with material deprivation in persons with multiple sclerosis in Switzerland: Cross-sectional data from the Swiss Multiple Sclerosis RegistryLisa Sanak, Christian P Kamm, Andrew Chan, et al.
Frontiers in Neurology|September 27, 2019
A Framework for Estimating the Burden of Chronic Diseases: Design and Application in the Context of Multiple SclerosisMarco Kaufmann, Milo Alan Puhan, Jens Kuhle, et al.
Swiss Medical Weekly|June 7, 2013
Tolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS diseaseCarmen Lienert, Gabriela Schawalder, Oliver Findling, et al.
Frontiers in Neurology|February 27, 2019
Tablet App Based Dexterity Training in Multiple Sclerosis (TAD-MS): Research Protocol of a Randomized Controlled TrialJudith J W van Beek, Erwin E H van Wegen, Cleo D Bol, et al.
Scientific Reports|November 17, 2018
T1-weighted Grey Matter Signal Intensity Alterations After Multiple Administrations of Gadobutrol in Patients with Multiple Sclerosis, Referenced to White MatterPeter Kelemen, Jamila Alaoui, Dominik Sieron, et al.
Pageof 9